OnePin Peptide Library · Repair & Recovery
BPC-157
Body Protection Compound · Pentadecapeptide BPC
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. The sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is stable in gastric acid, unlike most peptides.
Can be taken any time. For injury healing, inject near the injury site. Morning and evening dosing (split) may improve outcomes. No fasting required for SubQ. Empty stomach for oral.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
BPC-157 works through multiple complementary mechanisms:
Angiogenesis
Upregulates VEGF (vascular endothelial growth factor) and eNOS, promoting new blood vessel formation at injury sites. This increases nutrient and oxygen delivery to damaged tissue.
NO System Modulation
Acts as a stabilizer of the nitric oxide system, which regulates blood flow, inflammation, and cellular signaling. Unlike simple NO boosters, BPC-157 appears to normalize the system in both directions.
GH Receptor Upregulation
Increases growth hormone receptor expression in target tissues, amplifying the repair effects of both endogenous and exogenous growth hormone.
FAK-Paxillin Pathway
Activates focal adhesion kinase signaling, which drives cell migration to injury sites - a critical early step in tissue repair.
Collagen Synthesis
Promotes fibroblast activity and organized collagen deposition, supporting structural repair rather than scar formation.
Gut-Brain Axis
Interacts with the dopaminergic and serotonergic systems, which may explain its protective effects on both the GI tract and central nervous system.
What to expect
Days 1-7: Reduced inflammation and pain at injury site. Some users report noticeable improvement within 48 hours for acute injuries. Gut issues may show early relief. Injection site may have brief warmth or redness.
Weeks 2-4: Significant healing progress. Chronic injuries begin responding. Tendon and ligament pain markedly reduced. Gut permeability improving. Range of motion and function returning. This is where most users report the most dramatic changes.
Weeks 4-12: Structural repair consolidating. Chronic issues that took months to develop may need this longer timeframe. Collagen remodeling continuing. Some users continue at maintenance dose. Consider cycling off after 8-12 weeks.
Evidence
The honest take
BPC-157 can heal any injury
OverstatedOverstated. Animal studies show broad tissue repair capability, but 'any injury' is too absolute. It accelerates natural healing processes - it doesn't regenerate completely destroyed tissue. Structural tears may still need surgical intervention.
Partially true for acute injuries and pain reduction. Some users report rapid anti-inflammatory effects. However, structural healing (tendon, ligament, collagen) takes weeks regardless of BPC-157 use. It accelerates the timeline, not eliminates it.
Mostly accurate based on available evidence. Animal studies show remarkably clean safety profile with no established LD50. However, absence of evidence is not evidence of absence - long-term human safety data simply doesn't exist yet.
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Side effects & safety
Commonly reported
- Mild injection site redness or warmth (resolves in minutes)
- Occasional lightheadedness immediately post-injection
- Mild GI changes during gut healing (temporary)
Less common & notes
- Rarely reported: mild headache, fatigue in first few days, temporary nausea.
- BPC-157 has an exceptionally favorable safety profile in animal studies - no LD50 has been established because researchers could not find a lethal dose.
- However, long-term human safety data does not exist.
Pharmacokinetics
Storage. Reconstitute with bacteriostatic water. Store refrigerated at 2-8°C. Highly stable peptide - resistant to degradation, acid-stable. Shelf life 28-30 days after reconstitution. Do not freeze after reconstitution. Protect from prolonged light exposure. Slight yellow tint is normal and does not indicate degradation. Discard if cloudy or particulate matter visible.
Regulatory status
Not FDA-approved for any indication. Granted FDA Orphan Drug Designation for short bowel syndrome (Trials Pharma). Available through compounding pharmacies with prescription in some jurisdictions and through research chemical suppliers. Clinical trials initiated but not yet published. All current human use is experimental/off-label. Classified as a research peptide in most countries.
Put it to work
Calculate, log & track
Open BPC-157 straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open BPC-157 in the app →Go deeper
The guide & community
The complete BPC-157 walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗